Citius Pharmaceuticals, Inc. (CTXR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 13.72M |
| Enterprise Value | 11.28M |
| P/E Ratio | -0.28 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.94 |
| Price/Book Ratio | 0.24 |
| Enterprise/Revenue | -0.44 |
| Enterprise/EBITDA | 0.05 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -6.51 |
| Operating Margin | -8.64 |
| Return On Assets | -0.33 |
| Return On Equity | -0.67 |
| Revenue | 0 |
| Revenue/Share | 0.27 |
| Gross Profit | -214,250 |
| EBITDA | -38.2M |
| Net Income | -37.43M |
| Diluted EPS | -3.38 |
| Total Cash | 17.01M |
| Total Cash/Share | 0.65 |
| Total Debt | 7.18M |
| Total Debt/Equity | 0.11 |
| Current Ratio | 0.84 |
| Book Value Per Share | 2.9 |
| 52-Week Change | -55.54 |
| 52-Week High | 2.19 |
| 52-Week Low | 0.47 |
| Moving Average 50 Days | 0.59 |
| Moving Average 200 Days | 0.79 |
| Average Volume | 544,027 |
| Shares Outstanding | 11.17M |
| % Held by Institutions | 4.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | June 09, 2017 |